M R7 (Rabeprazole sodium delayed-release 20 mg)
Pill imprint M R7 has been identified as Rabeprazole sodium delayed-release 20 mg.
Rabeprazole is used in the treatment of gerd; barrett's esophagus; erosive esophagitis; duodenal ulcer; stomach ulcer (and more), and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Rabeprazole 20 mg is not a controlled substance under the Controlled Substance Act (CSA).
More about rabeprazole
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 52 Reviews – Add your own review/rating
- Drug class: proton pump inhibitors
- Rabeprazole delayed-release capsules
- Rabeprazole delayed-release tablets
- Rabeprazole (Advanced Reading)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.